Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0760
D

Failure to Monitor Blood Pressure Prior to Midodrine Administration

Toledo, Ohio Survey Completed on 12-04-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to obtain and document blood pressure readings prior to administering Midodrine, as ordered by the physician, for one resident with multiple complex diagnoses including dementia, morbid obesity, end stage renal disease, type 2 diabetes mellitus, obstructive sleep apnea, hypertension, metabolic encephalopathy, and dependence on renal dialysis. The physician's order specified that Midodrine 5 mg should be administered three times daily for hypotension, but to hold the medication if the systolic blood pressure was greater than 90. Medical record review showed that for the months of September and October, and for multiple days in November, there was no documentation that blood pressures were obtained before administering Midodrine to the resident. This was confirmed during an interview with a registered nurse, who verified the absence of blood pressure documentation prior to medication administration for the specified periods. The deficiency was identified during the investigation of two complaint numbers.

An unhandled error has occurred. Reload 🗙